top of page

Biosimilars finally taking off in the US

  • Writer: Laurent DECORY
    Laurent DECORY
  • Dec 12, 2020
  • 1 min read

Usage of Biosimilars has increased significantly in Europe, while usage in the US has been lagging behind.

Now, Biosimilars are finally taking off in the US thanks to Oncology blockbusters Bevacizumab (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin) and Infliximab (Remicade), creating a massive market opportunity.




Kommentarer


bottom of page